Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02341040 · ClinicalTrials.gov registry record
Evaluation of Potential Allergenicity of New Wheat Varieties
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02341040: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT02341040 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02341040 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The goal of the study is to determine accurate blood test levels that can predict whether or not subjects are truly allergic to certain foods. In this study, subjects that are clinically documented to be wheat-allergic will participate in a double blind oral food challenge. Blood will be collected from the subject to evaluate the potential allergenicity of proteins introduced into genetically modified crops and evaluate wheat-specific immunoglobulin-e (IgE) antibody reactivity to biotech and conventional wheat varieties.
Primary Outcome
Logistic regression analyses will be performed to establish diagnostic decision pointsindicating a high likelihood of symptomatic food allergy to wheat, thus potentiallypreventing unnecessary food challenges for patients with wheat allergy..
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-11 |
| Est. Completion | 2018-05-15 |
Why NCT02341040 stopped before completion
NCT02341040 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02341040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02341040 about?
NCT02341040 is a clinical study titled "Evaluation of Potential Allergenicity of New Wheat Varieties". The goal of the study is to determine accurate blood test levels that can predict whether or not subjects are truly allergic to certain foods. In this study, subjects that are clinically documented to be wheat-allergic will participate in a double blind oral food challenge. Blood will be collected f...
What is the current status of trial NCT02341040?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2014-11. Estimated completion is 2018-05-15.
Who is sponsoring clinical trial NCT02341040?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia